Annual Net Income
-$237.73 M
-$107.86 M-83.05%
December 31, 2023
Summary
- As of February 21, 2025, VRDN annual net profit is -$237.73 million, with the most recent change of -$107.86 million (-83.05%) on December 31, 2023.
- During the last 3 years, VRDN annual net income has fallen by -$127.02 million (-114.73%).
- VRDN annual net income is now -10906.20% below its all-time high of -$2.16 million, reached on December 31, 2013.
Performance
VRDN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$76.69 M
-$11.70 M-18.00%
September 30, 2024
Summary
- As of February 21, 2025, VRDN quarterly net profit is -$76.69 million, with the most recent change of -$11.70 million (-18.00%) on September 30, 2024.
- Over the past year, VRDN quarterly net income has dropped by -$29.03 million (-60.91%).
- VRDN quarterly net income is now -37585.01% below its all-time high of -$203.50 thousand, reached on December 31, 2013.
Performance
VRDN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$257.08 M
-$29.03 M-12.73%
September 30, 2024
Summary
- As of February 21, 2025, VRDN TTM net profit is -$257.08 million, with the most recent change of -$29.03 million (-12.73%) on September 30, 2024.
- Over the past year, VRDN TTM net income has dropped by -$40.42 million (-18.66%).
- VRDN TTM net income is now -47756.29% below its all-time high of -$537.20 thousand, reached on March 31, 2013.
Performance
VRDN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
VRDN Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -83.0% | -60.9% | -18.7% |
| 3 y3 years | -114.7% | -60.9% | -18.7% |
| 5 y5 years | -627.0% | -60.9% | -18.7% |
VRDN Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -199.4% | at low | -198.5% | at low | -223.7% | at low |
| 5 y | 5-year | -467.8% | at low | -1295.9% | +15.5% | -754.4% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +15.5% | <-9999.0% | at low |
Viridian Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$76.69 M(+18.0%) | -$257.08 M(+12.7%) |
| Jun 2024 | - | -$64.99 M(+33.9%) | -$228.06 M(+4.6%) |
| Mar 2024 | - | -$48.54 M(-27.4%) | -$218.13 M(-8.2%) |
| Dec 2023 | -$237.73 M(+83.0%) | -$66.86 M(+40.3%) | -$237.73 M(+9.7%) |
| Sep 2023 | - | -$47.66 M(-13.4%) | -$216.66 M(+9.5%) |
| Jun 2023 | - | -$55.06 M(-19.2%) | -$197.90 M(+14.8%) |
| Mar 2023 | - | -$68.15 M(+48.9%) | -$172.33 M(+32.7%) |
| Dec 2022 | -$129.87 M(+63.5%) | -$45.78 M(+58.4%) | -$129.87 M(+14.9%) |
| Sep 2022 | - | -$28.91 M(-2.0%) | -$113.03 M(+15.1%) |
| Jun 2022 | - | -$29.49 M(+14.8%) | -$98.17 M(+13.3%) |
| Mar 2022 | - | -$25.69 M(-11.2%) | -$86.65 M(+9.1%) |
| Dec 2021 | -$79.41 M(-28.3%) | -$28.95 M(+106.1%) | -$79.41 M(-43.8%) |
| Sep 2021 | - | -$14.04 M(-21.8%) | -$141.21 M(+6.4%) |
| Jun 2021 | - | -$17.96 M(-2.7%) | -$132.66 M(+9.5%) |
| Mar 2021 | - | -$18.46 M(-79.7%) | -$121.13 M(+9.4%) |
| Dec 2020 | -$110.72 M(+164.4%) | -$90.74 M(+1551.7%) | -$110.72 M(+267.9%) |
| Sep 2020 | - | -$5.49 M(-14.6%) | -$30.09 M(-16.0%) |
| Jun 2020 | - | -$6.43 M(-20.0%) | -$35.83 M(-6.4%) |
| Mar 2020 | - | -$8.04 M(-20.5%) | -$38.29 M(-8.6%) |
| Dec 2019 | -$41.87 M(+28.0%) | -$10.12 M(-9.9%) | -$41.87 M(-0.5%) |
| Sep 2019 | - | -$11.23 M(+26.2%) | -$42.07 M(+5.6%) |
| Jun 2019 | - | -$8.90 M(-23.5%) | -$39.85 M(+0.5%) |
| Mar 2019 | - | -$11.63 M(+12.7%) | -$39.67 M(+21.3%) |
| Dec 2018 | -$32.70 M | -$10.32 M(+14.5%) | -$32.70 M(+13.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$9.01 M(+3.4%) | -$28.77 M(+12.4%) |
| Jun 2018 | - | -$8.71 M(+87.0%) | -$25.59 M(+5.8%) |
| Mar 2018 | - | -$4.66 M(-27.0%) | -$24.19 M(-8.7%) |
| Dec 2017 | -$26.51 M(+109.2%) | -$6.39 M(+9.5%) | -$26.51 M(+3.2%) |
| Sep 2017 | - | -$5.83 M(-20.2%) | -$25.70 M(+18.4%) |
| Jun 2017 | - | -$7.31 M(+4.8%) | -$21.70 M(+28.4%) |
| Mar 2017 | - | -$6.98 M(+25.3%) | -$16.90 M(+33.3%) |
| Dec 2016 | -$12.67 M(+11.9%) | -$5.57 M(+202.9%) | -$12.67 M(+25.7%) |
| Sep 2016 | - | -$1.84 M(-26.6%) | -$10.08 M(-11.5%) |
| Jun 2016 | - | -$2.51 M(-9.1%) | -$11.40 M(-0.5%) |
| Mar 2016 | - | -$2.76 M(-7.4%) | -$11.45 M(+1.1%) |
| Dec 2015 | -$11.33 M(+43.6%) | -$2.98 M(-5.5%) | -$11.33 M(+6.8%) |
| Sep 2015 | - | -$3.15 M(+23.0%) | -$10.61 M(+16.7%) |
| Jun 2015 | - | -$2.56 M(-2.7%) | -$9.09 M(-7.4%) |
| Mar 2015 | - | -$2.63 M(+16.7%) | -$9.82 M(+24.4%) |
| Dec 2014 | -$7.89 M(+265.3%) | -$2.26 M(+37.9%) | -$7.89 M(+35.2%) |
| Sep 2014 | - | -$1.64 M(-50.2%) | -$5.84 M(+14.9%) |
| Jun 2014 | - | -$3.29 M(+365.9%) | -$5.08 M(+118.1%) |
| Mar 2014 | - | -$706.00 K(+246.9%) | -$2.33 M(+7.8%) |
| Dec 2013 | -$2.16 M(-70.0%) | -$203.50 K(-76.9%) | -$2.16 M(+10.4%) |
| Sep 2013 | - | -$879.60 K(+63.0%) | -$1.96 M(+81.7%) |
| Jun 2013 | - | -$539.70 K(+0.5%) | -$1.08 M(+100.5%) |
| Mar 2013 | - | -$537.20 K | -$537.20 K |
| Dec 2012 | -$7.21 M | - | - |
FAQ
- What is Viridian Therapeutics annual net profit?
- What is the all time high annual net income for Viridian Therapeutics?
- What is Viridian Therapeutics annual net income year-on-year change?
- What is Viridian Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly net income year-on-year change?
- What is Viridian Therapeutics TTM net profit?
- What is the all time high TTM net income for Viridian Therapeutics?
- What is Viridian Therapeutics TTM net income year-on-year change?
What is Viridian Therapeutics annual net profit?
The current annual net income of VRDN is -$237.73 M
What is the all time high annual net income for Viridian Therapeutics?
Viridian Therapeutics all-time high annual net profit is -$2.16 M
What is Viridian Therapeutics annual net income year-on-year change?
Over the past year, VRDN annual net profit has changed by -$107.86 M (-83.05%)
What is Viridian Therapeutics quarterly net profit?
The current quarterly net income of VRDN is -$76.69 M
What is the all time high quarterly net income for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly net profit is -$203.50 K
What is Viridian Therapeutics quarterly net income year-on-year change?
Over the past year, VRDN quarterly net profit has changed by -$29.03 M (-60.91%)
What is Viridian Therapeutics TTM net profit?
The current TTM net income of VRDN is -$257.08 M
What is the all time high TTM net income for Viridian Therapeutics?
Viridian Therapeutics all-time high TTM net profit is -$537.20 K
What is Viridian Therapeutics TTM net income year-on-year change?
Over the past year, VRDN TTM net profit has changed by -$40.42 M (-18.66%)